Vigabatrin in the Treatment of Childhood Epilepsies: A Single‐Blind Placebo‐Controlled Study

Epilepsia

Volumn 30, Issue 4, 1989, Pages 430-437

  Luna, David ^a   Dulac, Olivier ^a   Pajot, Nicole ^a   Beaumont, Daniel ^b  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

^b Merrell Dow Laboratories ^*  (France)

Author keywords

7 vinyl GABA; Anticonvulsants; Children; Drug induced abnormalities

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGITATION; CHILD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MAJOR CLINICAL STUDY; MALE; MYOCLONUS EPILEPSY; ORAL DRUG ADMINISTRATION; PETIT MAL; PRIORITY JOURNAL; SIDE EFFECT;

4-AMINOBUTYRATE TRANSAMINASE; ADOLESCENT; AGE FACTORS; AMINOCAPROIC ACIDS; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMPARATIVE STUDY; EPILEPSIES, MYOCLONIC; EPILEPSIES, PARTIAL; EPILEPSY; EPILEPSY, TEMPORAL LOBE; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT; MALE; PLACEBOS; TIME FACTORS; VIGABATRIN;

EID: 0024370883     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1989.tb05322.x     Document Type: Article

References (26)

1. Myoclonic epilepsies of infancy and childhood.
2. The relationship between GABA concentrations in brain and cerebrospinal fluid
3. Vigabatrin for refractory complex partial seizures: multicenter single‐blind study with long‐term follow‐up
4. Proposal for revised clinical and electroencephalographic classification of epileptic seizures
5. Proposal for classification of epilepsies and epileptic syndromes
6. Myoclonic astatic epilepsy of early childhood.
7. Childhood epileptic encephalopathy with diffuse spike‐waves (otherwise known as “petit mal variant”) or the Lennox syndrome
8. Gamma‐vinyl‐GABA: a single‐blind trial in patients with epilepsy
9. Gamma‐vinyl GABA: a double‐blind placebo‐controlled trial in partial epilepsy
10. Increased gamma‐aminobutyric acid (GABA), homocarnosine and beta‐alanine in cerebrospinal fluid of patients treated with gamma‐vinyl GABA (4‐amino‐hex‐5‐enoic acid)
11. Cellular compartments of GABA in brain and their relationship to anticonvulsant activity
12. Design, biochemistry and pharmacology of enzyme‐activated irreversible inhibitors of GABA‐aminotransferase.
13. Double‐blind, placebo‐controlled study of Vigabatrin (gamma‐vinyl GABA) in drug‐resistant epilepsy
14. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical observations
15. Effect of vigabatrin on epilepsy in mentally retarded patients: a 7 month follow‐up study
16. Pharmacology of GABA
17. Effects of GABAmimetics and GABA antagonist on spontaneous nonconvulsive seizures in Wistar rats.
18. Effects of gamma‐acetylenic GABA and gamma‐vinyl GABA on metrazol‐activated, and kindled seizures
19. The GABA postsynaptic membrane receptor‐ionophore complex. Site of action of convulsant and anticonvulsant drugs
20. Long‐term study of gamma‐vinyl GABA in the treatment of epilepsy
21. Double‐blind study of gamma‐vinyl GABA in patients with refractory epilepsy
22. Biochemical and clinical effects of gamma‐vinyl GABA in patients with epilepsy
23. Double‐blind dose reduction study of vigabatrin in complex partial epilepsy
24. Gamma‐hydroxybutyric acid, gamma‐aminobutyric acid, and petit mal epilepsy.
25. Validation of the phenomenon of regression of seizure frequency in epilepsy
26. Doubleblind study of vigabatrin in the treatment of drug‐resistant epilepsy